Clinical, laboratory, diagnostic and prognostic aspects of canine lymphoma: a retrospective study (original) (raw)

Abstract

During the period of 8 years, 120 dogs affected by lymphoma were referred to the veterinary teaching hospital of the University. Canine lymphoma was classified and staged using a standardised diagnostic approach that involved the acquisition of detailed clinical history, physical examination and extended laboratory workup including lymph node cytology. Additionally, immunophenotyping was available in 22 cases. Multicentric lymphoma was the

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (26)

  1. Baskin CR, Couto CG, Wittum TE (2000) Factors influencing first remission and survival in 145 dogs with lymphoma: a retrospec- tive study. J Am Anim Hosp Assoc 36:404-409
  2. Capurro C, Buracco P, Rossi L (1990) Il linfoma nel cane: aspetti clinici e opzioni terapeutiche. Veterinaria 4(4):15-29
  3. Carter RF, Valli VE, Lumsden JH (1986) The cytology, histology and prevalence of cell types in canine lymphoma classified according the National Cancer Institute Working Formulation. Can J Vet Res 50:154-164
  4. Dhaliwal R, Kitchell BE, Messick JB (2004) Il linfosarcoma nel cane: caratteristiche cliniche. Veterinaria 18(2):39-47
  5. Dorn CR, Taylor DON, Frye FL et al (1968) Survey of animal neoplasms in Alameda and Contra Costa Countries, California. 1. Methodology and description of cases. J Natl Cancer Inst 40:295-305
  6. Dorn CR, Taylor DON, Schneider R (1970) The epidemiology of canine leukemia and lymphoma. Bibl Hemat 36:403-415
  7. Frimberger AE (2002) New protocols for canine lymphoma. Tufts Animal Expo, North Grafton MA, USA
  8. Fournel-Fleury C, Magnol JP, Bricaire P et al (1997) Cytohistological and immunological classification of canine malignant lympho- mas: comparison with human non-Hodgkin's lymphomas. J Comp Pathol 117:35-39. doi:10.1016/S0021-9975(97)80065-5
  9. Gavazza A, Presciuttini S, Barale R, Lubas G et al (2001) Association between canine malignant lymphoma, living in industrial areas and use of chemicals by dog owners. J Vet Intern Med 15:190- 195. doi:10.1892/0891-6640(2001)015<0190:ABCMLL>2.3. CO;
  10. Gavazza A, Lubas G, Valori E et al (2008) Retrospective survey of malignant lymphoma cases in the dog: clinical, therapeutical and prognostic feature. Vet Res Commun 32:S291-S293. doi:10.1007/s11259-008-9131-1
  11. Greenlee PG, Filippa D, Quimby FW et al (1990) Lymphomas in dogs. A morphologic, immunologic and clinical study. Cancer 66:480-490. doi:10.1002/1097-0142(19900801)66:3<480::AID- CNCR2820660314>3.0.CO;2-X
  12. Hahn KA (2002) Lymphoma good COP, bad COP. ACVIM (Oncology), Houston, TX
  13. Hayes HM, Tarone RE, Cantor KP et al (1991) Case-control study of canine malignant lymphoma: positive association with dog- owner's use of 2,4-dichlorophenoxyacetic acid and herbicides. J Natl Cancer Inst 83:1226-1231. doi:10.1093/jnci/83.17.1226
  14. Madewell BR (1986) Hematological and bone marrow cytological abnormalities in 75 dogs with malignant lymphoma. J Am Anim Hosp Assoc 22:235-240
  15. Madewell BR, Feldman BF, O'Neil S (1980) Coagulation abnormal- ities in dogs with neoplastic disease. Thromb Haemost 44:35-38
  16. Merlo DF, Rossi L, Pellegrino C et al (2008) Cancer incidence in pet dogs. J Vet Intern Med 22(4):976-984
  17. Ponce F, Magnol JP, Ledieu D et al (2004) Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy. Vet J 167:158-166. doi:10.1016/j.tvjl.2003. 10.009
  18. Price G, Page R, Fisher B et al (1991) Efficacy and toxicity of doxorubucin/cyclophosphamide maintenance therapy in dogs with multicentric lymphosarcoma. J Vet Intern Med 5:259-262
  19. Priester WA, MacKay FW (1980) The occurrence of tumors in domestic animals. Natl Cancer Inst Monogr 54:166
  20. Raskin RE, Krehbiel JD (1989) Prevalence of leukemic blood and bone marrow in dogs with multicentric lymphoma. J Am Vet Med Assoc 194:1427-1429
  21. Simon D, Moreno SN, Hirschberger J et al (2008) Efficacy of a continuous, multiagent chemotherapeutic protocol versus a short- term single-agent protocol in dogs with lymphoma. J Am Vet Med Assoc 232(6):879-885
  22. Teske E, Heerde P, Rutteman GR et al (1994a) Prognostic factors in canine non-Hodgkin's lymphomas. A prospective study in 138 dogs. J Am Vet Med Assoc 205(12):1722-1728
  23. Teske E, Wisman P, Moore PF et al (1994b) Histologic classification and immunophenotyping of canine non-Hodgkin's lymphomas: unexpected high frequency of T cell lymphomas with B cell morphology. Exp Hematol 22:1179-1187
  24. Tomley FM, Armstrong SJ, Mahy BW et al (1983) Reverse transcriptase activity and particles of retroviral density in cultured canine lymphosarcoma supernatants. Br J Cancer 47:277-284
  25. Vail DM (2000) Lymphoma. In: Feldman BF, Zinkl JG, Jain NC, Lea, Febiger (eds) Schalm's veterinary hematology. 5th edn. Lippin- cott, Philadelphia, pp 620-625
  26. Withrow SJ, Vail DM (2007) Withrow and MacEwen's small animal clinic oncology, 4th edn. Saunders Elsevier, Missouri, pp 699-